Natural Language Processing

LLM-based diagnostic systems achieve high semantic accuracy on benchmarks, but open-ended evaluation on clinically uncommon presentations reveals a systematic gap between headline accuracy and verifiable clinical reliability. We evaluate an LLM+rare-disease-RAG pipeline across two cohorts and show that the paradigm produces confident outputs that are frequently unverifiable and systematically resistant to clinician interrogation. We present NSIDDx (Neuro-Symbolic Integrated Differential Diagnosis System), a design framework arguing that DDx systems in low-resource settings must treat the clinician as an active reasoning agent. We instantiate this through a neuro-symbolic pipeline with ternary symptom encoding, contradiction detection, audit strings, and practitioner override - running offline on consumer hardware. We distill five design principles for clinician-in-the-loop clinical NLP and invite the prospective studies needed to validate the claim at scale.

Understanding which countries are represented in NLP datasets is essential for identifying gaps, targeting data collection, measuring progress, and informing AI policy. However, geographic metadata is very rarely available, and country-level representation is often hidden behind broad language-level claims. We introduce AtlasNLP, a country-aware atlas of over 13,000 NLP dataset records across normalized NLP task categories, tracking both the populations represented and where datasets are produced. AtlasNLP includes AtlasNLP-Gold, a human-curated reference set, and AtlasNLP-Core, an ACL-derived large-scale collection. Using this resource, we show that (1) dataset coverage is highly uneven across countries and tasks; (2) dataset production and representation are geographically asymmetric; and (3) language coverage does not imply geographic representation. These findings reveal blind spots in current dataset documentation practices and motivate more explicit geographic metadata for country-aware NLP evaluation.